Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated with Poor Outcomes in Advanced Biliary Cancers Treated with Platinum-Based Chemotherapy

Pedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H. Ahn, Jason S. Starr, Jeremy C. Jones, Hani Babiker, Samantha R. Inabinett, Natasha Wylie, Ashton W.R. Boyle, Tanios S. Bekaii-Saab, Gregory J. Gores, Rory Smoot, Michael Barrett, Bolni Nagalo, Nathalie Meurice, Natalie Elliott, Joachim PetitYumei Zhou, Mansi Arora, Chelsae Dumbauld, Oumar Barro, Alexander Baker, James Bogenberger, Kenneth Buetow, Aaron Mansfield, Kabir Mody, Mitesh J. Borad

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated with Poor Outcomes in Advanced Biliary Cancers Treated with Platinum-Based Chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences